hotspot -WSS

hotspot

author：entertainment 2025-10-04 06:39:22 - browse：69

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

Fresh off of the news that its drug Wegovy may not just help people lose weight, but could also lower cardiac risks, Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a small Canadian biotech with a new approach to weight loss.

Novo will spend up to $1 billion to buy Inversago Pharma, which is developing an oral obesity drug that targets the cannabinoid receptor CB1. It’s the second big obesity acquisition this year, following Eli Lilly’s move to purchase startup Versanis Bio.

Drugs like Wegovy are in a class called GLP-1 drugs, which mimic the effects of the glucagon-like peptide 1 hormone that help people feel full by targeting the hormone’s receptors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Sen. Paul opposes bill to ban Chinese biotechs

WSS

Sen. Paul opposes bill to ban Chinese biotechs

Sen. Paul opposes bill to ban Chinese biotechs

Novo Nordisk obesity pill bests Wegovy in early trial

Change Healthcare payments predicted restored March 15

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

Wikipedia

hotspot

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Just how do doctors, lawmakers, and the public define abortion?

New air purifier tech could be key to improving indoor air quality

RSV shot was 90% effective at preventing hospitalizations in kids

How one medical school became remarkably diverse

First medicine developed to treat MASH expected to be approved soon

BioMarin wins approval for gene therapy to treat hemophilia A

Adele warns fans about throwing things at performers onstage

Moonlake's readout produced a cash windfall. Risks remain

Former medical device CEO who sold dummy, plastic parts convicted of fraud

hotspot

Following judge's order, DOJ releases slightly less

Following judge's order, DOJ releases slightly less

EU moves toward latest gene techniques in food production to counter climate change, shortages

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

UnitedHealth quietly bought dozens of outpatient centers

Change Healthcare cyberattack prompts Medicare loan program

hotspot

focus

focus

Wikipedia